A carregar...

Explaining The Cost Of Biotech Therapies

Health plans and employers are strategizing about how to finance biotech therapies, which can run five and six figures per patient per year. The challenge to manufacturers is to communicate the value of their products now – before someone defines it for them.

Na minha lista:
Detalhes bibliográficos
Autor principal: EDELMAN, BILL
Formato: Artigo
Idioma:Inglês
Publicado em: BioCommunications LLC 2004
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3555164/
https://ncbi.nlm.nih.gov/pubmed/23372497
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!